Is there an association between perceived social support and cardiovascular health behaviours in people with severe mental illnesses?


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 14 09 2019
accepted: 02 05 2020
pubmed: 20 5 2020
medline: 21 11 2020
entrez: 20 5 2020
Statut: ppublish

Résumé

People with severe mental illnesses (SMI) have an increased risk of cardiovascular disease (CVD). Research in the general population suggests that social support may protect against increased CVD morbidity and mortality; however, this may not apply to those with SMI. We aimed to explore the association between perceived social support and attendance at primary care nurse CVD risk reduction clinic appointments and CVD risk-reducing behaviours in an SMI population with elevated CVD risk factors. We used longitudinal and cross-sectional data from a randomised controlled trial on 326 adults with SMI recruited via 76 general practices in England. Multilevel regression analysis estimated the effect of perceived social support on attendance at CVD risk reduction clinic appointments over 6 months, and adherence to CVD medication, physical activity, diet, smoking and alcohol use at baseline, adjusted by age, sex, ethnicity, deprivation, psychiatric diagnosis and employment. Perceived social support predicted greater appointment attendance in unadjusted (IRR = 1.005; 1.000-1.010; p = 0.05) but not adjusted analysis (IRR = 1.003; 0.998-1.009; p = 0.25). Perceived social support was associated with greater adherence to medication; for each 1% increase in social support, there was a 4.2% increase in medication adherence (OR = 1.042; 1.015-1.070; p = 0.002). No association was found between greater perceived social support and greater physical activity, lower sedentary behaviour, healthier diet, lower alcohol use or being a non-smoker. Social support may be an important facilitator for CVD medication adherence and is potentially important for primary care appointment attendance; however, alternative strategies might be needed to help people with SMI engage in physical activity, healthier diets and to reduce their smoking and alcohol use.

Identifiants

pubmed: 32424502
doi: 10.1007/s00127-020-01879-9
pii: 10.1007/s00127-020-01879-9
pmc: PMC7585561
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1659-1669

Subventions

Organisme : Department of Health
ID : RP-PG-0609-10156
Pays : United Kingdom
Organisme : Programme Grants for Applied Research
ID : RP-PG-0609-10156

Références

Issues Ment Health Nurs. 2005 Apr;26(3):341-51
pubmed: 16020051
Am J Psychiatry. 2017 Mar 1;174(3):246-255
pubmed: 27631964
Arch Gen Psychiatry. 2007 Feb;64(2):242-9
pubmed: 17283292
Community Ment Health J. 2015 Aug;51(6):654-62
pubmed: 25682283
Am J Manag Care. 2012 Dec 01;18(12):e461-7
pubmed: 23286676
J Epidemiol Community Health. 1999 Mar;53(3):165-72
pubmed: 10396494
N Engl J Med. 2017 Aug 24;377(8):733-744
pubmed: 28834483
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Diabetes Spectr. 2018 May;31(2):189-192
pubmed: 29773940
J Affect Disord. 2016 Sep 01;201:145-52
pubmed: 27235817
BMC Cardiovasc Disord. 2013 Jul 06;13:48
pubmed: 23829636
Acta Psychiatr Scand. 2006 Apr;113(4):298-305
pubmed: 16638074
Br J Psychiatry Suppl. 2004 Apr;47:S112-4
pubmed: 15056604
BMC Psychiatry. 2016 Feb 20;16:36
pubmed: 26896958
J Subst Abus Alcohol. 2017;5(1):
pubmed: 29881770
Psychiatr Rehabil J. 2013 Jun;36(2):65-71
pubmed: 23647144
J Nerv Ment Dis. 2005 Oct;193(10):641-6
pubmed: 16208158
J Health Psychol. 2007 Jul;12(4):563-79
pubmed: 17584809
Patient Prefer Adherence. 2018 May 10;12:793-802
pubmed: 29785094
Am J Health Behav. 2017 Nov 1;41(6):810-821
pubmed: 29025509
Schizophr Res. 2011 Jul;129(2-3):104-10
pubmed: 21550783
J Affect Disord. 2004 Oct 1;82(1):143-7
pubmed: 15465589
Psychiatr Serv. 2011 Apr;62(4):353-9
pubmed: 21459985
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Yonsei Med J. 2005 Jun 30;46(3):331-40
pubmed: 15988803
Front Psychiatry. 2017 Aug 04;8:135
pubmed: 28824466
Schizophr Res. 2017 Jan;179:2-7
pubmed: 27623360
Soc Psychiatry Psychiatr Epidemiol. 2015 Jul;50(7):1111-20
pubmed: 25106666
J Dual Diagn. 2018 Jan-Mar;14(1):32-39
pubmed: 29351507
Open Addict J. 2011 Nov 11;4:58-64
pubmed: 23264842
Trials. 2016 Feb 12;17:80
pubmed: 26868949
Psychiatr Q. 2017 Dec;88(4):701-710
pubmed: 28091796
J Ment Health. 2013 Feb;22(1):42-50
pubmed: 23343046
J Ment Health. 2019 Oct;28(5):475-481
pubmed: 28675331
Addict Behav. 2015 Feb;41:169-74
pubmed: 25452062
BMC Public Health. 2012 Jan 21;12:65
pubmed: 22264236
Fam Pract. 1994 Dec;11(4):375-81
pubmed: 7895964
Soc Psychiatry Psychiatr Epidemiol. 2007 Oct;42(10):787-93
pubmed: 17721669
Nord J Psychiatry. 2013 Feb;67(1):22-9
pubmed: 22429047
Australas Psychiatry. 2014 Feb;22(1):71-7
pubmed: 24191294
Health Technol Assess. 2018 Nov;22(65):1-160
pubmed: 30499443
Psychol Bull. 1985 Sep;98(2):310-57
pubmed: 3901065
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
J Aging Health. 2015 Apr;27(3):403-31
pubmed: 25253728
J Acad Nutr Diet. 2017 Aug;117(8):1272-1278
pubmed: 28483451
J Clin Epidemiol. 2011 Mar;64(3):255-7; discussion 258-63
pubmed: 21144706
Br J Psychiatry. 2002 Oct;181:321-5
pubmed: 12356659
Schizophr Res. 2006 Feb 28;82(2-3):225-31
pubmed: 16360305
PLoS Med. 2010 Jul 27;7(7):e1000316
pubmed: 20668659
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
Can J Psychiatry. 2013 Jan;58(1):59-65
pubmed: 23327758
Aust N Z J Psychiatry. 2012 Jul;46(7):669-75
pubmed: 22645397
Lancet Psychiatry. 2018 Feb;5(2):145-154
pubmed: 29396118
JAMA Psychiatry. 2014 Dec 1;71(12):1350-63
pubmed: 25321337
Br J Psychiatry. 2017 Sep;211(3):175-181
pubmed: 28684403
Soc Psychiatry Psychiatr Epidemiol. 2001 Nov;36(11):523-8
pubmed: 11824845
Soc Psychiatry Psychiatr Epidemiol. 2006 Oct;41(10):761-70
pubmed: 16900304
J Stud Alcohol. 2000 Sep;61(5):744-50
pubmed: 11022815
Addict Behav. 2019 Feb;89:248-255
pubmed: 30343187
Psychosom Med. 1976 Sep-Oct;38(5):300-14
pubmed: 981490
Psychol Assess. 2000 Jun;12(2):186-92
pubmed: 10887764

Auteurs

Alexandra Burton (A)

Division of Psychiatry, University College London, Maple House, 6th floor, 149 Tottenham Court Road, London, W1T 7NF, UK. a.burton@ucl.ac.uk.

Kate Walters (K)

Department of Primary Care and Population Health, University College London, UCL Medical School (Royal Free Campus), Upper Third Floor, Rowland Hill Street, London, NW3 2PF, UK.

Louise Marston (L)

Department of Primary Care and Population Health, University College London, UCL Medical School (Royal Free Campus), Upper Third Floor, Rowland Hill Street, London, NW3 2PF, UK.

David Osborn (D)

Division of Psychiatry, University College London, Maple House, 6th floor, 149 Tottenham Court Road, London, W1T 7NF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH